AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood cancer immune therapy trial ends early after just 2 patients
Disease control TerminatedThis early-stage study tested a new drug called INKmune in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The goal was to see if it was safe and to find the best dose. Only 2 people took part before the study was stopped early.
Matched conditions: AML
Phase: PHASE1 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Gene mutation study in AML reveals key insights
Knowledge-focused TerminatedThis study aimed to find how often IDH1/2 gene mutations occur in adults with acute myeloid leukemia (AML) and how these mutations affect patient outcomes. Researchers analyzed stored leukemia samples from over 1,000 patients. The goal was to better understand the disease, not to…
Matched conditions: AML
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC